Detrol LA In Men With Overactive Bladder.

Completed · Phase 4

Conditions studied: Overactive Bladder (OAB)

In brief

An interventional active/placebo double blinded parallel randomized controlled study in which at 12 weeks of treatment, the primary endpoint of patient perception of bladder condition is measured along with associated safety and other secondary endpoints like bladder diary endpoints, quality of life and patient treatment satisfaction. Patients included in the study must have symptoms of OAB (frequency of at least 8 per day and Urgency of at least 1 episode per day confirmed by bladder diary). Patients are not eligible to enroll in the study if they have/had significant hepatic or renal disease, history of radiation treatment.

Key facts

Study ID

NCT00282932

Run by

Pfizer's Upjohn has merged with Mylan to form Viatris Inc.

People needed

600

Starts

2006-01-01

Expected to finish

2007-05-14

Last updated by the study team

2021-01-27

Who can join

Age: 40 and older. Sex: male. Healthy volunteers: not accepted.

You may qualify if…

• Symptoms of OAB (frequency more than 8 per day and Urgency more than 1 episode per day confirmed by bladder diary)

You may not qualify if…

• Significant hepatic or renal disease, history of radiation treatment

Where it is running

• Pfizer Investigational Site — La Mesa, California, United States
• Pfizer Investigational Site — Aurora, Colorado, United States
• Pfizer Investigational Site — Iowa City, Iowa, United States
• Pfizer Investigational Site — Shreveport, Louisiana, United States
• Pfizer Investigational Site — Watertown, Massachusetts, United States
• Pfizer Investigational Site — Woodlane, New Jersey, United States
• Pfizer Investigational Site — New York, New York, United States
• Pfizer Investigational Site — Cincinnati, Ohio, United States
• Pfizer Investigational Site — State College, Pennsylvania, United States
• Pfizer Investigational Site — Houston, Texas, United States
• Pfizer Investigational Site — Calgary, Alberta, Canada
• Pfizer Investigational Site — Surrey, British Columbia, Canada
• Pfizer Investigational Site — Victoria, British Columbia, Canada
• Pfizer Investigational Site — Kingston, Ontario, Canada
• Pfizer Investigational Site — London, Ontario, Canada
• Pfizer Investigational Site — Oakville, Ontario, Canada
• Pfizer Investigational Site — Toronto, Ontario, Canada
• Pfizer Investigational Site — Toronto, Ontario, Canada
• Pfizer Investigational Site — Toronto, Ontario, Canada
• Pfizer Investigational Site — Montreal, Quebec, Canada
• Pfizer Investigational Site — Montreal, Quebec, Canada
• Pfizer Investigational Site — Pointe-Claire, Quebec, Canada
• Pfizer Investigational Site — Aalborg, Denmark
• Pfizer Investigational Site — Herlev, Denmark
• Pfizer Investigational Site — Anaheim, California, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.